logo
मेसेज भेजें

High Purity GS-441524 Antiviral API for FIP Treatment with Stable Structure and Controlled Production

10 शीशियाँ
MOQ
US$20/vial-US$30/vial
कीमत
High Purity GS-441524 Antiviral API for FIP Treatment with Stable Structure and Controlled Production
विशेषताएं गेलरी उत्पाद विवरण एक बोली का अनुरोध
विशेषताएं
निर्दिष्टीकरण
प्रोडक्ट का नाम: जीएस-441524
पैकेजिंग: 6मिली, 8मिली, 10मिली
दवाई लेने का तरीका: इंजेक्शन
कैस: 1191237-69-0
प्रशासन मार्ग: अंतस्त्वचा इंजेक्शन
ताकत: 20मिग्रा, 30मिग्रा
निर्माण का देश: चीन
मूल: चीन
समारोह: बिल्ली एफआईपी के लिए उपचार
आपूर्ति की योग्यता: Fedex/Ups/DHL
प्रमुखता देना:

High Purity GS-441524

,

Stable Structure FIP Treatment

,

Controlled Production Antiviral API

मूलभूत जानकारी
उत्पत्ति के प्लेस: चीन
ब्रांड नाम: LongilatBio
भुगतान & नौवहन नियमों
पैकेजिंग विवरण: 10 शीशी / डिब्बा
प्रसव के समय: 2-3 दिन
भुगतान शर्तें: एल/सी,डी/ए,डी/पी,टी/टी,वेस्टर्न यूनियन,速汇金
आपूर्ति की क्षमता: 100, 000 शीशी प्रति माह
उत्पाद विवरण
High Purity GS-441524 Antiviral Research API
Stable Structure Controlled Production
Product Introduction
GS-441524 is a nucleoside analog compound commonly referenced in feline infectious peritonitis (FIP) management programs. In veterinary settings, it is supplied as an injectable solution and applied under professional supervision.
The injectable format allows systemic absorption and is often selected in situations where stable and predictable dosing is required during FIP support protocols.
Product Specifications
ItemDetails
Product NameGS-441524
CAS Number1191237-69-0
Dosage FormInjection
Strength20mg / 30mg
Packaging6ml / vial, 8ml / vial, 10ml / vial
Storage ConditionRoom Temperature
Expiry Date1 Year from Date of Manufacture
Country of ManufactureChina
IndicationManagement Support for Cat FIP
Each vial is labeled with batch number and manufacturing date for traceability.
High Purity GS-441524 Antiviral API for FIP Treatment with Stable Structure and Controlled Production 0
About Feline Infectious Peritonitis (FIP)
Feline Infectious Peritonitis (FIP) is a progressive viral disease caused by mutation of feline coronavirus. It typically presents as:
  • Wet (Effusive) FIP
  • Dry (Non-effusive) FIP
  • Ocular involvement
  • Neurological involvement
Different clinical forms may require different dosage considerations.
Reference Dosage Guidelines
Dosage should be determined by a licensed veterinarian based on body weight and clinical status.
Common reference protocols:
  • FIP (Wet): 0.3 ml × body weight (kg) + 0.1 ml residue
  • FIP (Dry): 0.4 ml × body weight (kg) + 0.1 ml residue
  • Eye / Nerve Involvement: 0.5 ml × body weight (kg) + 0.1 ml residue
  • Recurrence Cases: 0.6 ml × body weight (kg) + 0.1 ml residue
Body weight should be monitored regularly during the treatment cycle.
Product Characteristics
  • Injectable systemic delivery
  • Two concentration options (20mg / 30mg)
  • Room temperature storage
  • Multiple vial sizes available
  • Clear labeling and batch tracking
The formulation is prepared to maintain stability within recommended storage conditions for up to one year.
Packaging & Handling
Each vial is sealed to minimize contamination risk.
Store in a dry environment at room temperature. Avoid prolonged light exposure.
Important Notice
For veterinary use only.
Treatment plans should be determined by qualified professionals in accordance with local regulations.
अनुशंसित उत्पाद
हम से संपर्क में रहें
व्यक्ति से संपर्क करें : Mrs. Nancylee
दूरभाष : +86 15508667508
शेष वर्ण(20/3000)